In vivo dosimetry is recommended as a defence-in-depth strategy in radiotherapy treatments and is currently employed by clinics around the world. The characteristics of a new optically stimulated luminescence dosimetry system were investigated for the purpose of replacing an aging thermoluminescence dosimetry system for in vivo dosimetry. The stability of the system was not sufficient to satisfy commissioning requirements and therefore it has not been released into clinical service at this time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s13246-015-0365-2 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!